A call to arms: on refining  microsatellite marker panels for comparing global diversity by unknown
Sutton Malaria Journal 2013, 12:447
http://www.malariajournal.com/content/12/1/447RESEARCH Open AccessA call to arms: on refining Plasmodium vivax
microsatellite marker panels for comparing
global diversity
Patrick L SuttonAbstract
Background: Microsatellite (MS) markers have become an important tool for studying the population diversity,
evolutionary history and multiplicity of infection (MOI) of malaria parasite infections. MS are typically selected on
the basis of being highly polymorphic. However, it is known that the polymorphic potential (mutability) of each
marker can vary as much as two orders of magnitude, which radically changes how diversity is represented in the
genome from one marker to the next. Over the past decade, approximately 240 Plasmodium vivax MS have been
published, comprising nine major panels of markers. Inconsistent usage of each panel has resulted in a surfeit of
descriptive genetic diversity data that are largely incomparable between populations. The objective of this study
was to statistically evaluate the quality of individual MS markers in order to validate a refined panel of markers that
will provide a balanced picture of P. vivax population diversity.
Methods: All previously published data, including genetic diversity indices, MS parameters, and population
parameters, were assembled from 18 different global studies into a flat file to facilitate statistical analysis and
modelling using JMP® Genomics 6.0 (SAS Institute Inc, Cary, NC, USA). Statistical modeling was employed to
down-select markers with extreme variation among the mean number of alleles, expected heterozygosity,
maximum repeat length and/or chromosomal location of the repeat. Individual MS were analysed by step-down
whole model linear regression and standard least squares fit models, both stratified by annual parasite incidence
to identify MS markers with values significantly different from the mean.
Results: Of the 42 MS under evaluation in this study, 18 (nine high priority) were identified as ideal candidates for
measuring population diversity between global regions, while five (two high priority) additional markers were
identified as candidates for MOI studies.
Conclusions: MS diversity was found to be a function of endemicity and motif structure. Evaluation of individual
MS permitted the assembly of a refined panel of markers that can be reliably utilized in the field to compare
population structures between global regions.
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Microsatellite (MS) DNA sequences are short tandem re-
peats, typically comprised of one (mono-) to six (hexa-)
nucleotides (motifs), which repeat continuously without
interruption (perfect repeat type), with intermittent nu-
cleotide disruption (imperfect repeat type), with interrupt-
ing insertions (interrupted repeat type) or in tandem with
a different motif (compound repeat type). MS are caused
and maintained by mutation events, such as replication
slippage and/or slip-strand mismatch repair, which in-
duces sequence length variation through expansions/inser-
tions and contractions/deletions of the repeating motif(s)
[1-4]. Regardless of repeat type, the total number of re-
peats in the MS is referred to as the repeat length. Vari-
ation in the repeat length causes size polymorphisms
within the locus, which can be used to differentiate organ-
isms in population diversity studies [5,6]. Given their
mechanisms of mutation, MS are often considered neutral.
However, this is somewhat debated due to the fact that
MS are scattered throughout intergenic and intragenic re-
gions of most chromosomes; therefore, it is important to
consider the location prior to data interpretation in an ef-
fort to subscribe to this neutral theory. Although MS lack
the strain diversity resolution that whole genome sequen-
cing provides, these markers remain an effective and easily
deployable method for high-throughput genotyping in the
field at moderate cost. Compared with single nucleotide
polymorphism (SNP) genotyping, MS can provide in-
creased resolution due to a higher polymorphic potential
(i e, more alleles per locus), but can be problematic to in-
terpret, standardize and calibrate across multiple studies.
Since the introduction of MS in population diversity
studies, great insight has been gained into the amount of
observed and expected genetic diversity within extant pop-
ulations of eukaryotic parasites [7-16]. For malaria para-
sites, MS have rapidly become a popular alternative to
polymorphic antigenic genes due to their purported neu-
trality, ubiquity throughout genomes and utility for de-
scribing the evolutionary history of global populations.
Furthermore, the relatively unconstrained polymorphic na-
ture of MS loci permits increased detection of multiclonal
infections [17], which can be useful when describing the
history of endemicity and the stability of transmission
within a specific global region [18,19]. For Plasmodium
vivax, the utility of these markers may even extend to de-
scribing infection dynamics across time, e g, whether an in-
dividual is presenting with a relapse, recrudescence or
reinfection [12,20-22]. One of the major objectives in Plas-
modium global diversity studies is to generate data that
can be compared between populations of differing geog-
raphies, ecologies, climates, endemicities, and transmission
intensities; however, such studies require standardizing ex-
perimental and analytical methods across a large and geo-
graphically separated community of researchers [23,24].Unlike the frequently used Plasmodium falciparum
MS marker panel published by Anderson et al. [8], there
are approximately nine different panels of P. vivax MS
markers (including two panels with minisatellites with
motifs that exceed six nucleotides) [12,25-32], describing
at least 240 loci scattered throughout the genome. The
majority of these MS markers were identified in silico
and their polymorphic nature tested on DNA from refer-
ence strains [12,25-32]. However, in the last decade there
have been at least 22 studies investigating P. vivax MS
population diversity across seven global regions, 17
countries, and at 47 different field sites. Of the markers
utilized in these studies (N = 68), only 42 have been
tested in more than one field site, and seven of these are
second-generation versions of a previously published
marker, which results in moderately redundant popula-
tion diversity data. Consequently, there are many sets of
descriptive data that remain largely incomparable, owing
to minimal genetic marker overlap between studies.
In most studies, microsatellites are selected on the basis
of being highly polymorphic. However, it is known that
the polymorphic potential of each marker can vary as
much as two orders of magnitude, which radically changes
how diversity is represented in the genome from one
marker to the next [33-35]. The objective of this study was
to statistically evaluate the quality of the MS markers cur-
rently in use, in order to generate a refined panel of
markers that will provide a balanced picture of P. vivax
genomic diversity. A statistically validated P. vivax MS
panel would provide at least two benefits to the P. vivax
community. First, statistical evaluation provides a means
of assessing marker suitability at the outset of a study, for
the purpose of describing population structure and multi-
plicity of infection (MOI). The inherent mutability of the
repeat region is not easily assessed in the absence of long-
term in vitro culture, which is not routine for P. vivax
parasites due to their strict preference for reticulocytes.
However, the quality of MS markers can be evaluated sta-
tistically by investigating the association between diversity
level and endemicity, as well as, the repeat length [36-43],
motif length, repeat type and location of the tandem re-
peat. The second benefit derived from the use of a stan-
dardized panel is the ability to compare population
parameters, such as diversity and structure between global
regions, which is a basic premise of population genetics
studies. Before these benefits can be realized, the current
MS marker panels must be re-evaluated and if possible
consolidated to permit a more comprehensive and com-
parative approach to P. vivax population diversity across
global populations.
Analyses resulted in a standardized panel of 18 (nine
high priority) high-quality MS markers distributed across
nine chromosomes. These markers are ideal for popula-
tion diversity studies, as they will reliably describe overall
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also accommodating a wide range of polymorphic vari-
ation. Additionally, a panel of five (two high priority)
highly polymorphic MS markers was identified for MOI
studies. These markers consistently exceed the predicted
diversity level within different global regions and are suit-
able for describing infections with more than clone due to
a possible increased mutability. Standardized usage of
these panels will facilitate a clearer understanding of the
history of this parasite as it has evolved in different eco-
logical and epidemiological niches.
Methods
Microsatellite marker selection
Of the ~240 MS markers that have been described in the
literature, 42 were selected for this study because each had
been used in more than one field study, and therefore
could be compared. These 42 MS markers were verified
against the reference genomes [25,44], tested for redun-
dancy against all published MS loci, located in the genome
(intergenic or intragenic), and identified by repeat type
(perfect or non-perfect, which includes all repeat types that
are not deemed perfect). Of the 42 MS markers, seven
were found to be second-generation versions of a previ-
ously published marker (first-generation), which had either
been redesigned to optimally capture the repeat region
or were unknowingly duplicated during the discovery
stage (NCBI Primer Blast). In most studies, the second-
generation marker was used in the same study as the first-
generation marker, permitting a direct comparison among
genetic diversity indices. In all cases, variation between
first- and second-generation markers was insignificant. As
a result, only data from the first-generation markers was
utilized in this study, however, second-generation markers
are identified throughout this manuscript in “( )” immedi-
ately following the first-generation name. Concatenating
these multi-generation markers resulted in a final panel of
35 discrete MS markers. Further, genomic location with re-
spect to presence within intergenic or intragenic regions
was determined. Of the 35 markers, 20 were located in
known or hypothetical genes, while only 15 were located in
non-coding intergenic regions. The repeat type also varied,
with 26 MS markers identified as having perfect repeats
and nine with non-perfect repeats. Additional file 1 de-
scribes each of the MS loci analysed in this study.
Data consolidation
All previously published data, including genetic diversity
indices (ie, number of alleles per locus and expected
heterozygosity (He) and repeat length size), MS parame-
ters (ie, location, repeat type, and motif length) and
population parameters (ie, regional location, annual pa-
rasite incidence (API) and sample sizes), were assem-
bled from 18 different global studies (representing sevenregions, 14 countries, and 35 field sites) into a single
database to facilitate statistical analysis and modelling
using JMP® Genomics 6.0 (©2012 SAS Institute Inc,
Cary, NC, USA). See Additional file 2 for a summary of
studies included in the analysis.
Given the fact that genetic diversity is a function of
endemicity, it was essential to establish endemicity cat-
egories to stratify downstream analyses. However, the re-
ported metrics for calculating malaria incidence varied
extensively across the global regions examined in this
study. In an effort to accommodate this variation, all
metrics were simplified by converting them to the “an-
nual parasite incidence” (API - the number of micro-
scopically confirmed malaria cases during one year per
1,000) during the time at which the samples were col-
lected for each study. Previously described methods for
classifying endemicity [45] were utilized to permit cat-
egorical transformation of the numerical API values
(≤0.05 stratum, hypo-endemic and typically focal trans-
mission; >0.05 stratum, meso- to hyper-endemic) to fa-
cilitate data analysis.
Defining the polymorphic potential of individual MS
The objective of this study was to identify quality MS
markers in order to generate a refined panel of markers
that will provide a balanced picture of P. vivax genomic
diversity. Given the fact that the polymorphic potential of
each marker can generate unequal variation [33-35], statis-
tical modelling was employed to down-select markers with
extreme variation. Number of alleles, expected heterozy-
gosity (He) and/or repeat lengths in excess of the mean
may indicate unregulated polymorphic potential, with
heightened heterogeneity that can obscure downstream
population parameter estimations (Figure 1). Although
MS markers in excess of the mean may not directly trans-
late into distinct and observable patterns within the para-
site population structure, these markers can be used as
tools to define the MOI. Conversely, a reduction of alleles,
He, and/or repeat length may not provide a strong enough
signal to discern population structure when it does exist
(Figure 1). Though no studies have indicated an overall re-
duction in MS diversity, this is expected to become more
of a concern in regions with elimination platforms, as di-
versity decreases with reduced transmission. Markers in
significant excess of the mean are termed “Excess”, those
significantly reduced from the mean are termed “Re-
duced”, and those with no difference from the mean are
termed “Balanced”. For these reasons, markers that deviate
significantly from the mean in either direction were down-
selected from the final core panel of markers, which can
be used to clearly define the population structure without
bias from excess or reduced diversity (Figure 2). In all
cases, individual MS were analysed in step-down whole
model linear regression and standard least squares fit
Figure 1 Population structure scenarios based on the polymorphic potential of microsatellite markers. (i) Markers generating reduced
diversity due to reduced mutability will not be able to resolve existing population structure; (ii) markers generating excess diversity due to
increased mutability may confound local population structure, making it difficult to compare different geographic regions; (iii) markers with
balanced diversity, calibrated to the population comparisons of interest, can decipher population structure and provide meaningful insight into
parasite migration and evolution.
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values significantly different from the mean.
Results and discussion
MS diversity as a function of endemicity
The amount of genetic diversity within a region is a
function of parasite incidence [46-48], and high quality
MS markers should reflect this relationship (Figure 3a).
To test the overall link between diversity and endem-
icity, diversity indices for all MS markers across all glo-
bal studies were correlated with the categorical API
strata. For the API >0.05 stratum, the mean number of
alleles per locus (x = 11.4, σ = 11.9, 95% CI = 9.4, 13.4),
mean He (x = 0.79, σ = 0.15, 95% CI = 0.76, 0.81) and the
mean maximum repeat length (x = 36.3, σ = 19.8, 95%
CI = 33.0, 40.0) was significantly higher than the mean
number of alleles per locus (x = 6.7, σ = 5.4, 95% CI =
6.0, 7.4), mean He ( x = 0.63, σ = 0.24, 95% CI = 0.60,
0.66) and the mean maximum repeat length (x = 31.8,
σ = 18.9, 95% CI = 29.4, 34.2) in the API ≤0.05 stratum
(p <0.0001, p <0.0001 and p = 0.0294, ANOVA, respect-
ively) (Figure 3b). This confirms that genetic diversity is
a function of parasite endemicity, as regions with greater
endemicity are expected to have a greater repertoire of
genetically diverse parasites circulating in the popula-
tion. Individual analysis for each MS, including down-
selection data and panel recommendations, can be found
in Figure 2.
Polymorphic potential of repetitive regions
Understanding the role of microsatellite parameters
on diversity
Earlier reports considering the polymorphic potential of
P. vivax MS identified differences in motif length and re-
peat length as likely causes for allelic variation between
MS markers [37,41,43]; however, much of this discussion
was had prior to the publication of the draft genome
[25] and subsequent whole genome sequencing projects[44,49]. In other organisms, like fruit flies, humans and
chimpanzees, researchers have found that certain motifs,
based on their length and nucleotide composition, have
higher rates of mutability than others, suggesting that
repeat length is an intrinsic function of motif mutability
[36,38-40]. However, this circularity of this hypothesis is
difficult to break and one cannot help but question the
root cause for increased mutability, as the size of the
repeat must in part be a of the function of motif mut-
ability. Here, both motif length and repeat length are
re-investigated, as well as, the genomic location of the
tandem repeat (intergenic versus intragenic) and the re-
peat type (perfect, interrupted, compound or interrupted
and compound) as likely factors for MS mutability.
Motif length as a function of MS diversity
The 35 markers included in this study displayed five dif-
ferent motif lengths: di- (n = 2), tri- (n = 18), tetra- (n =
8), hepta- (n = 2), and octa- (n = 2) nucleotide. Though
the hepta- and octa-nucleotide motifs are not true
microsatellites, but rather minisatellites, the use of these
markers in more than one field site warrants consideration
in this analysis. Of these five motif lengths, tri-nucleotide
motifs revealed the most dynamic range of polymorphic
potential, with the largest range of alleles (range = 1–103),
He (range = 0.01-0.99) and maximum repeat length
(range = 10–87). Octa-nucleotide motifs revealed the
most conservative polymorphic potential, with the smal-
lest range of alleles (range = 2–13), He (range = 0.01-0.9)
and maximum repeat length (range = 10–17) (Figure 4);
though an increased sample size is required to have ad-
equate power to be confident in this result.
Next, a linear regression was used to determine the rela-
tionship between motif length and the mean number of al-
leles per locus, He and maximum repeat length for all MS,
stratified by API. There were no significant correlations
between motif length and the mean number of alleles per
locus or He in either API stratum (Figure 4). However, in
MS Marker



















PvMS7 Balanced Balanced Balanced Balanced Balanced 1° Panel 2 (A) [31]
3.502 Balanced Balanced Balanced Balanced Balanced 1° Panel 3 (A) [28]
3.503 Balanced Balanced Balanced Balanced Balanced 1° Panel 3 (B) [28]
MS1 Balanced Balanced Balanced Balanced Balanced 1° Panel 3 (C) [30]
ms033 (PvMS5) Balanced Balanced Balanced Balanced Balanced 1° Panel 3 (D) [29, 31]
MS12 Balanced Balanced Balanced Balanced Balanced 1° Panel 5 (A) [30]
MS15 Balanced Balanced Balanced Balanced Balanced 1° Panel 5 (B) [30]
MS4 (ms050) Balanced Balanced Balanced Balanced Balanced 1° Panel 6 (A) [29, 30]
ms038 (PvMS9) Balanced Balanced Balanced Balanced Balanced 1° Panel 6 (B) [29, 31]
MS9 (Pv6635) Balanced Balanced Balanced Balanced Balanced 1° Panel 8 (A) [29, 32]
MS20 (ms116) Balanced Balanced Balanced Balanced Balanced 1° Panel 10 (A) [29, 30]
MS6 Balanced Balanced Balanced Balanced Balanced 1° Panel 11 (A) [30]
11.162 Balanced Balanced Balanced Balanced Balanced 1° Panel 11 (B) [28]
MS10 Balanced Balanced Balanced Balanced Balanced 1° Panel 13 (A) [30]
13.239 Balanced Balanced Balanced Balanced Balanced 1° Panel 13 (B) [28]
PvMS8 Balanced Balanced Balanced Balanced Balanced 1° Panel 13 (C) [31]
14.297 Balanced Balanced Balanced Balanced Balanced 1° Panel 14 (A) [28]
PVMS6 Balanced Balanced Balanced Balanced Balanced 1° Panel 14 (B) [31]
PvMS2 Balanced
Reduced
Balanced Balanced Balanced 2° Panel 3 (A) [31]
(p < 0.03)
MS2 Balanced Balanced Balanced Balanced
Excess




Balanced Balanced 2° Panel 6 (B) [30]
(p < 0.05)
6.34 Balanced Balanced Balanced Balanced
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Balanced Balanced Balanced 2° Panel 14 (A) [32]
(p < 0.02)
3.27
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MOI 3 (A) [28]





MOI 8 (A) [28]





Balanced MOI 8 (B) [31]





MOI 9 (A) [30]
(p < 0.0001) (p < 0.0004) (p < 0.05) (p < 0.001)
MS8 (ms206)
Excess Excess Excess
Balanced Balanced MOI 12 (A) [29, 30]





Exclude 1 (A) [28]





Exclude 4 (A) [30]
(p < 0.05) (p < 0.02)
PvMS10 Balanced
Reduced Reduced Reduced
Balanced Exclude 5 (A) [31]
p < 0.003 p < 0.01 p < 0.01
MS7
Reduced Reduced Reduced Reduced Reduced
Exclude 12 (A) [30]





Exclude 12 (B) [31]
(p < 0.04) (p < 0.02)
Figure 2 Summary of statistically validated P. vivax MS for usage in population diversity and MOI studies. MS diversity indices (mean
number of alleles per locus, expected heterozygosity, and maximum repeat length) were correlated with six microsatellite and population
parameters (endemicity, motif length, repeat length, repeat type and genomic position) to identify MS with excess, reduced or balanced diversity
in comparison with the mean. Balanced in both API categories (API >0.05 or API ≤0.05) is indicated in green. Excess or reduced in API >0.05,
API ≤0.05 or both is indicated in white, black and gray, respectively. Based on this data, MS were categorized into four recommended groups:
1° Panel, 2° Panel, Exclude, and MOI. “1° Panel” indicates balanced diversity in all six test categories and usage as the primary panel of markers for
measuring population diversity. “2° Panel” indicates markers with significant excess or reduction of diversity in one of six test categories. These
markers should be used cautiously, as they may misrepresent the diversity level due to inherent unbalanced mutability. “Exclude” indicates
markers with significant reduction in diversity in more than one of the six test categories. These markers are not recommended, as they
consistently result in a misrepresentation of population diversity due to reduced polymorphic potential. “MOI” (multiplicity of infection) indicates
MS markers that consistently have significant excess diversity in more than one test category. MOI markers are ideal for identifying multiclonal
infections. For chromosomes with more than one MS marker tested, priority has been assigned (A-D). Priority is based on the total number of
studies that have utilized the marker, with a higher priority being placed on markers that have been used more frequently. Bold font indicates
markers of highest priority.
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a b
Figure 3 a, b MS diversity is a function of parasite endemicity. (a) Schematic illustrating that population diversity increases as a function of
increased endemicity, captured by parasite incidence and transmission; (b) for all MS markers combined, the box plots compare the mean
number (no) of alleles per locus (y-axis, blue), expected heterozygosity (He) (y-axis, red) and maximum repeat length (y-axis, green) between
different API categories (x-axis). Character values (A and B) denote statistical significance between API strata (p <0.0001, ANOVA).
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relation between motif length and mean maximum repeat
length (p <0.0001, ANOVA, bivariate fit), suggesting that
shorter motif lengths may generate an increased number
of repeats; however, this is not reflected in the number of
alleles per locus (Figure 4). This correlation exists only as
a trend for the >0.05 API stratum (p = 0.349, ANOVA, bi-
variate fit), likely due the limited usage of hepta- and octa-
nucleotide motifs in regions of higher endemicity (Fig-
ure 4). Regardless, the negative correlation between motif
length and repeat length establishes the motif structure
as an important factor to be considered when selecting
MS markers for genetic diversity studies. Individual
analysis for each MS, including down-selection data
and panel recommendations, can be found in Figure 2.Repeat length as a function of MS diversity
Previous studies have reported that the mutability of the
repeat region may be guided by the repeat length, as in-
creased replication slippage is probable in sequences
with high repeat numbers [21,38,41-43]. In this study,
repeat length was highly variable, ranging from seven to
87 repeats across the 35 MS markers. Statistical modelling
was used to correlate the mean number of alleles per locus
and He with the mean maximum number of repeats in the
repeat length array across all studies, stratified by API. In
both API strata, API ≤0.05 and API >0.05, there was a sig-
nificant positive linear correlation between the number of
alleles per locus (p = 0.0011 and p = 0.0240, ANOVA, bi-
variate fit, respectively) and He (p <0.0001 and p = 0.0064,
ANOVA, bivariate fit, respectively) with increasing repeat
length (Figure 5). These results confirm previous work
by Russell et al. [37] and provide additional insight intothe maintenance of tandem repeats, as the parasites are
transmitted with different rates in regions of differing
endemicity. Individual analysis for each MS, including
down-selection data and panel recommendations, can
be found in Figure 2.Repeat type as a function of MS diversity
Sequence analysis of MS loci has revealed that MS may
exist in either perfect or non-perfect types. Perfect
microsatellites will have a repeated motif that continues
uninterrupted for a specific repeat length, while non-
perfect microsatellites may exist as imperfect, inter-
rupted or compound repeats. Although hard evidence is
lacking for the cause of these non-perfect repeat types,
the generation of single point mutations within a MS
motif may offer some explanation for imperfect repeats,
while interrupted repeat types may be caused by inser-
tion mutations and compound repeat types may be the
result of recombinatory events. Regardless of the mech-
anistic cause, the mutability of these different repeat
types is of considerable interest as it may assist in the se-
lection of quality MS loci for population diversity studies.
As mentioned in the Methods section, of the 35 markers
examined in this study, 26 MS markers were identified as
having perfect repeats and nine were defined as non-
perfect (either imperfect, interrupted or compound). For
the purpose of this analysis the repeat type, limited to per-
fect versus non-perfect repeat types, was correlated with
the mean number of alleles per locus, He and maximum
repeat length (stratified by API).
On the most basic level, non-perfect repeat types ap-
pear to be associated with increased diversity in all di-
versity indices, regardless of API stratification. In the
r2 = 0.0005, p = 0.8359 r2 = 0.0015, p = 0.5424 
r2 = 0.0031, p = 0.5132 r2 = 0.0019, p = 0.5009 







Figure 4 Motif length as a function of MS diversity. For all MS markers combined, the box plots compare the mean number (no) of alleles
per locus (y-axis, blue), expected heterozygosity (He) (y-axis, red) and maximum repeat length (y-axis, green) across all motif lengths (x
1°-axis),
stratified API (x2°-axis). There were no significant correlations between motif length and the mean no of alleles per locus (panels i, ii) or mean He
(panels iii, iv) in either API stratum. However, in the ≤0.05 API stratum there was a significant negative correlation between motif length and
mean maximum repeat length (panel vi) (p <0.0001, ANOVA, bivariate fit). This correlation exists only as a trend for the >0.05 API stratum (panel v)
(p = 0.349, ANOVA, bivariate fit).
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for the non-perfect repeats (x = 48.3, σ = ±17.7, 95%
CI = 44.3, 52.3) was significantly higher than the mean
for perfect repeats (x = 23.9, σ = ±13.6, 95% CI = 22.0,
26.0) (p <0.0001, ANOVA) (Figure 6). A similar observa-
tion was made in the API >0.05 stratum, where the
mean maximum repeat length for the non-perfect re-
peats ( x = 49.6, σ = ±19.3, 95% CI = 44.5, 54.8) was
also significantly higher, compared with perfect repeats
(x = 27.1, σ = ±14.1, 95% CI = 24.0, 30.2) (p <0.0001,
ANOVA) (Figure 6). Significance between these repeat
types was also achieved when considering the mean
number of alleles per locus and the He in the API >0.05
stratum. Non-perfect repeats had a significantly higher
mean number of alleles per locus (x = 16.2, σ = ±16.5,
95% CI = 11.8, 20.6) and He (x = 0.82, σ = ±0.15, 95%
CI = 0.78, 0.86), when compared with the mean numberof alleles per locus (x = 8.1, σ = ±5.2, 95% CI = 6.9, 9.2)
(p <0.0001, ANOVA) and He (x = 0.77, σ = ±0.14, 95%
CI = 0.73, 0.80) (p = 0.0192, ANOVA) of the perfect re-
peats (Figure 6).
However, it seems counterintuitive that non-perfect
repeats might generate increased diversity levels in these
populations. Further investigation of these repeat types
revealed that when compared with perfect repeats (x =
4.0, σ = ±1.9, 95% CI = 3.8, 4.2), non-perfect repeats (x =
3.1, σ = ±0.31, 95% CI = 3.1, 3.2) are significantly biased
towards smaller motif lengths (p <0.0001, ANOVA),
which were previously found to be associated with in-
creased diversity levels in the population. Therefore, it is
more likely that the increased diversity found to be asso-
ciated with non-perfect repeats is a byproduct of the ac-
tual motif structure or the combination of different
repeating motifs when the non-perfect repeat is a
r2 = 0.1868, p < 0.0001 r2 = 0.0434, p = 0.0011 





Figure 5 Repeat length as a function of MS diversity. For all MS markers combined, the box plots compare the mean number (no) of alleles
per locus (y-axis, blue) and expected heterozygosity (He) (y-axis, red) across repeat length (x
1°-axis), stratified API (x2°-axis). In both API strata,
API ≤0.05 (panels ii, iv) and API >0.05 (panels i, iii), the mean no of alleles per locus (p = 0.0011 and p = 0.0240, ANOVA, bivariate fit,
respectively) and mean He (p <0.0001 and p = 0.0064, ANOVA, bivariate fit, respectively) were positively correlated with the repeat length.
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ing down-selection data and panel recommendations,
can be found in Figure 2.
Genomic position as a function of MS diversity
The proximity of a MS to a coding region in the genome
will likely influence the polymorphic potential within the
locus. For example, recent studies in P. falciparum have
indicated that He in MS is inversely correlated with the
proximity of the MS locus to the P. falciparum chloro-
quine resistance transporter gene, which is known to be
associated with chloroquine resistance in this parasite
[50-53]. This relationship is likely a result of genetic
hitchhiking, but is still important to consider when
selecting MS loci to describe genetic diversity in a popu-
lation as it may impact the polymorphic potential. As
previously mentioned, of the 35 markers examined in
this study, 20 were located in known (N = 8) or hypo-
thetical genes (N = 12), while only 15 were located in
non-coding intergenic regions. For the purpose of this
analysis the genomic position was correlated with the
mean number of alleles per locus, He and maximum re-
peat length (stratified by API).For the both API strata, there were no significant differ-
ences among the mean number of alleles per locus or
mean He between intergenic and intragenic regions. How-
ever, in both API strata, API ≤0.05 and API >0.05, the
mean maximum repeat length did vary significantly be-
tween intergenic (x = 24.0, σ = ±13.5, 95% CI = 21.2, 26.7;
x = 31.1, σ = ±13.0, 95% CI = 27.2, 35.0) and intragenic
(x = 36.8, σ = ±20.1, 95% CI = 33.6, 40.1; x = 38.8, σ = ±
22.0, 95% CI = 34.2, 43.3, respectively), with intragenic loci
having significantly higher numbers of repeats than inter-
genic regions (p <0.0001 and p = 0.0303 for API ≤0.05 and
API >0.05, respectively, ANOVA) (Figure 7). To help ex-
plain this finding, genomic position was correlated with
repeat type (perfect versus non-perfect) and motif length.
In this study, intragenic MS are significantly comprised of
non-perfect repeat types compared with the intergenic
MS, 44.1% compared with 23.3%, respectively (p <0.0001,
Fisher’s Exact). Likewise, these highly diverse intragenic
markers are significantly biased towards smaller motif
lengths (p <0.0001, ANOVA). Neglecting to observe an in-
crease in the mean number of alleles or He, would likely
negate the possibility that these intragenic regions have in-
creased polymorphic potential, but again, this analysis
A B 
B 










Figure 6 Repeat type as a function of MS diversity. For all MS markers combined, the box plots compare the mean number (no) of alleles per
locus (y-axis, blue), expected heterozygosity (He) (y-axis, red) and maximum repeat length (y-axis, green) across different repeat types (x
1°-axis),
stratified API (x2°-axis). Character values (A and B) denote statistical significance between perfect and non-perfect repeat types, within each API
category. In the API >0.05 stratum, non-perfect repeat types had a significantly higher mean no of alleles per locus (panel i) (p <0.0001, ANOVA),
mean He (panel iii) (p = 0.0192, ANOVA) and mean maximum repeat length (panel v) (p <0.0001, ANOVA) than perfect repeat types. In the
API ≤0.05 stratum, non-perfect repeat types had a significantly higher mean maximum repeat length (panel vi) (p <0.0001, ANOVA) than perfect
repeat types. No significant differences were found between repeat types for either the mean no of alleles per locus (panel ii) or mean He in the
API ≤0.05 stratum (panel iv).
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the structure of the motif and the amount of genetic diver-
sity present in the MS. Individual analysis for each MS, in-
cluding down-selection data and panel recommendations,
can be found in Figure 2.
Conclusions
Genetic diversity data were mined from 18 population
diversity studies (Additional file 1) in an effort to evalu-
ate the quality of data generated from published P. vivax
MS markers (N = 42, reduced to N = 35 after NCBI Pri-
mer Blast indicated redundancies) and also to produce
recommended MS panels for both population diversity
and MOI studies. Though there is a convention among
population diversity studies to select MS markers with
extremely high polymorphic potential, there are MS with
increased and decreased mutation rates that will falsely
inflate and deflate the genetic diversity of parasite popu-
lation, respectively. Therefore, when considering individ-
ual MS, markers may generate excess, reduced orbalanced (no difference) diversity when compared with
the mean across all markers (Figure 1). Given the inher-
ent unequal MS mutability [33-35], data quality was ex-
amined by using robust step-down statistical models
that compared the genetic diversity metrics (number of
alleles per locus, He and maximum repeat lengths) of in-
dividual MS markers with the mean of all MS markers
(stratified by API) to examine the impact of parasite en-
demicity, motif length, repeat length, repeat type and
genomic position as a function of MS diversity. Individ-
ual analysis for each MS, including down-selection data
and panel recommendations, can be found in Figure 2.
As expected, the results indicated that the amount of
genetic diversity present within all global regions is a
function of parasite endemicity; individual MS analysis
revealed that five of the 35 markers were in significant
excess of the mean, while two were significantly reduced
from the mean (Figure 2, Figure 3a,b). Other factors,
such as the motif length and repeat length, were also sig-
nificantly correlated with the amount of diversity present
A A 
A 










Figure 7 Genomic position as a function of MS diversity. For all MS markers combined, the box plots compare the mean number (no) of
alleles per locus (y-axis, blue), expected heterozygosity (He) (y-axis, red) and maximum repeat length (y-axis, green) across different genomic
positions (x1°-axis), stratified API (x2°-axis). Character values (A and B) denote statistical significance between intergenic and intragenic locations,
within each API category. For the both API strata, there were no significant differences among the mean no of alleles (panels i, ii) per locus or
mean He (panels iii, iv) between intergenic and intragenic regions. In both API strata, API ≤0.05 (panel vi) and API >0.05 (panel v), the mean
maximum repeat length did vary significantly between intergenic and intragenic, with intragenic loci having significantly higher numbers of
repeats than intergenic regions (p <0.0001 and p = 0.0303 for API ≤0.05 and API >0.05, respectively, ANOVA).
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motifs, shorter motifs were associated with increased
genetic diversity; six MS markers were in significant ex-
cess of the mean, while five were significantly reduced
(Figure 2, Figure 4). Longer repeat lengths, rather than
shorter repeat lengths, were positively correlated with
greater diversity; four of the MS markers were in signifi-
cant excess of the mean, while three were significantly
reduced (Figure 2, Figure 5). Further, non-perfect repeats
and intragenic MS also correlated significantly with in-
creased genetic diversity. For repeat type, there were
three MS in significant excess of the mean and two sig-
nificantly reduced from the mean (Figure 2, Figure 6);
while MS location revealed four in significant excess
of the mean and five significantly reduced from the
mean (Figure 2, Figure 7). However, non-perfect repeat
types were biased towards being located within intra-
genic regions and shorter motifs with longer repeat
lengths tended to comprise both non-perfect repeats
and intragenic MS. Therefore, it is difficult to com-
pletely resolve the total impact of these MS parame-
ters on genetic diversity.
The availability of a validated refined panel of MS
markers will greatly facilitate the development of im-
proved comparative population genetics algorithms, whichwill in turn generate a better understanding of the migra-
tion and evolution of this species. Based on the analyses in
this study, MS markers have been categorized into four
groups: (1) 1° Panel, (2) 2° Panel, (3) Excluded and (4)
MOI (Figure 2). For chromosomes with more than one
MS marker tested, a priority ranking has been assigned
(A-D) (Figure 2). Priority is based on the total number of
studies that have utilized the marker, with a higher priority
being placed on markers that have been used more fre-
quently. “1° Panel” (N = 18) indicates balanced diversity in
all test categories and usage as the primary panel of
markers for decoding population diversity and structure.
It is recommended that future studies utilize MS markers
with “A” priority ranking (N = 9, bold font) to facilitate
population diversity comparison between global regions,
as these markers have previously been used with the high-
est frequency. “2° Panel” (N = 7) indicates significant ex-
cess or reduction in diversity in one test category. It is
recommended that the 2° Panel markers be used cau-
tiously as additional markers to the 1° Panel, as the re-
sulting population structure may be skewed towards
decreased or increased diversity due to the inherent unbal-
anced mutability of the MS marker. “Exclude” (N = 5) in-
dicates significant reduction in diversity in more than one
test category. If selected for a population diversity study, it
Sutton Malaria Journal 2013, 12:447 Page 11 of 12
http://www.malariajournal.com/content/12/1/447is recommended that the data be thoroughly scrutinized,
as these markers will result in a skewed interpretation of
population diversity due to the reduced polymorphic po-
tential of these MS markers. “MOI” (N = 5) indicates MS
markers that consistently have significant excess diversity
in more than one test category. MOI markers are highly
recommended for identifying multiclonal infections. Two
of these five MS markers (3.27 and MS8 (ms206), bold
font) are highly recommended for MOI studies due to
having extreme excess diversity in more than one test cat-
egory across both API strata.
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